Triumeq 5 mg / 60 mg / 30 mg dispersible tablets
- Licence status
- Active substances
- Dolutegravir sodium, Lamivudine, Abacavir sulfate
- Dosage Form
- Dispersible tablet
- Licence number
- EU/1/14/940/001-003
- Licence holder
- ViiV Healthcare BV
Product documents
Licence information
- ATC code
- J05AR13 Antivirals for treatment of HIV infections, combinations
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/02/2023